GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Xbrane Biopharma AB (OSTO:XBRANE) » Definitions » Days Inventory

Xbrane Biopharma AB (OSTO:XBRANE) Days Inventory : 174.94 (As of Dec. 2023)


View and export this data going back to 2016. Start your Free Trial

What is Xbrane Biopharma AB Days Inventory?

Days Inventory is also known as Days Sales of Inventory (DSI). Xbrane Biopharma AB's Average Total Inventories for the three months ended in Dec. 2023 was kr120.3 Mil. Xbrane Biopharma AB's Cost of Goods Sold for the three months ended in Dec. 2023 was kr62.7 Mil. Hence, Xbrane Biopharma AB's Days Inventory for the three months ended in Dec. 2023 was 174.94.

The historical rank and industry rank for Xbrane Biopharma AB's Days Inventory or its related term are showing as below:

OSTO:XBRANE' s Days Inventory Range Over the Past 10 Years
Min: 64.13   Med: 125.67   Max: 223718.29
Current: 157.82

During the past 11 years, Xbrane Biopharma AB's highest Days Inventory was 223718.29. The lowest was 64.13. And the median was 125.67.

OSTO:XBRANE's Days Inventory is ranked better than
57.16% of 649 companies
in the Biotechnology industry
Industry Median: 191.36 vs OSTO:XBRANE: 157.82

Xbrane Biopharma AB's Days Inventory declined from Dec. 2022 (55,929.57) to Dec. 2023 (174.94).

Inventory Turnover measures how fast the company turns over its inventory within a year. Xbrane Biopharma AB's Inventory Turnover for the three months ended in Dec. 2023 was 0.52.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Xbrane Biopharma AB's Inventory-to-Revenue for the three months ended in Dec. 2023 was 1.80.


Xbrane Biopharma AB Days Inventory Historical Data

The historical data trend for Xbrane Biopharma AB's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Xbrane Biopharma AB Days Inventory Chart

Xbrane Biopharma AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Days Inventory
Get a 7-Day Free Trial Premium Member Only Premium Member Only 110.37 - - 223,718.29 140.96

Xbrane Biopharma AB Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Days Inventory Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 55,929.57 101.86 172.71 190.76 174.94

Competitive Comparison of Xbrane Biopharma AB's Days Inventory

For the Biotechnology subindustry, Xbrane Biopharma AB's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Xbrane Biopharma AB's Days Inventory Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Xbrane Biopharma AB's Days Inventory distribution charts can be found below:

* The bar in red indicates where Xbrane Biopharma AB's Days Inventory falls into.



Xbrane Biopharma AB Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Xbrane Biopharma AB's Days Inventory for the fiscal year that ended in Dec. 2023 is calculated as

Days Inventory (A: Dec. 2023 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (A: Dec. 2022 ) + Total Inventories (A: Dec. 2023 )) / count ) / Cost of Goods Sold (A: Dec. 2023 )*Days in Period
=( (50.26 + 106.856) / 2 ) / 203.412*365
=78.558 / 203.412*365
=140.96

Xbrane Biopharma AB's Days Inventory for the quarter that ended in Dec. 2023 is calculated as:

Days Inventory (Q: Dec. 2023 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (Q: Sep. 2023 ) + Total Inventories (Q: Dec. 2023 )) / count ) / Cost of Goods Sold (Q: Dec. 2023 )*Days in Period
=( (133.662 + 106.856) / 2 ) / 62.728*365 / 4
=120.259 / 62.728*365 / 4
=174.94

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Xbrane Biopharma AB  (OSTO:XBRANE) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

Xbrane Biopharma AB's Inventory Turnover for the three months ended in Dec. 2023 is calculated as

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Xbrane Biopharma AB's Inventory to Revenue for the three months ended in Dec. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.


Xbrane Biopharma AB Days Inventory Related Terms

Thank you for viewing the detailed overview of Xbrane Biopharma AB's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.


Xbrane Biopharma AB (OSTO:XBRANE) Business Description

Traded in Other Exchanges
Address
Retzius vag 8, Solna, SWE, 171 65
Xbrane Biopharma AB is a biotechnology company that develops biosimilars. The company has a patented protein production platform with up to 12 times greater productivity than standard systems for the production of proteins in E.coli host cells. Xbrane's leading product candidate is Ximluci, a ranibizumab biosimilar (original drug Lucentis) used in the treatment of various eye diseases, mainly the wet form of age-related macular degeneration. The company's geographical segments include the Middle East, Asia, Europe, and the United States.

Xbrane Biopharma AB (OSTO:XBRANE) Headlines

No Headlines